Authors


Luke Twelves, MD, MBA

Latest:

Pharmacists and Providers: Key Collaborators in the Shift Toward Decentralized and Virtual Health Care

Virtual health care enhances patient experiences, integrates complex data, and ensures medication access through provider-pharmacist collaboration.


Lesley Archer, PharmD Candidate

Latest:

The Community Pharmacist’s Role in the Management of Migraine

Migraine is a chronic neurological disease characterized by throbbing or pulsating unilateral or bilateral headache that can last from hours to days.


Amer El-Ghali, PharmD

Latest:

2022-2023 Influenza Season Looks to Be Severe

Outpatient treatment is primarily based on patient-specific factors, whereas oseltamivir remains the therapy of choice for inpatient settings.


Amanda Rachidi, PharmD

Latest:

PBM Reform Takes Off in 2025

Meaningful reform was challenging in 2024, but this year could turn the tide.


Todd Watkins

Latest:

Partnership Between Public Health and Pharmacy: Opportunities to Increase Resource Sharing, Efficiency, and Improved Health Outcomes

Additional support is necessary to ensure that infrastructure development continues and that all pharmacists have the necessary tools to continue to provide immunization services.


Mickenzie Meyers, PharmD Candidate

Latest:

2022 ACC Consensus on Role of Nonstatin Therapies for LDL-Cholesterol Lowering

Since the 2018 guideline’s publication, additional non-statin therapies such as bempedoic acid, evinacumab, and inclisiran, have been approved by the FDA for the management of hypercholesterolemia.


Jeremy M. Ebersole, MS

Latest:

Designing for Safety: The Pharma Industry’s Role in Preventing Medication Errors

Pharmaceutical companies must consider formulation, packaging, and labeling from the start to minimize errors and protect patients.


Javier Munoz, MD, MBA

Latest:

Future Treatment Landscape of MZL

Closing out their discussion on marginal zone lymphoma, the panel considers which future treatment strategies are most promising.



Ken Perez

Latest:

The Societal Case for Pharmacist Provider Status

Beyond the benefits to the pharmacist profession, granting provider status to pharmacists addresses the larger societal problem of growing physician shortages.


Mark Gregory

Latest:

Asembia AXS25: Emotional Support Transforms Specialty Pharmacy Patient Care

Specialty pharmacy experts discuss how emotional support, addressing patient loneliness, and peer-to-patient programs can significantly improve medication adherence and patient care.


Jennifer Kolb

Latest:

Building a Future Workforce: Pharmacies Partner with High Schools to Sponsor Students Through Pharmacy Tech Program

A projected shortage of trained staff in the years ahead demands looking beyond normal hiring channels.


Liz Hess, PharmD, MS, FISMP, CPPS

Latest:

Wellness Support Group Shows Promise in Reducing Burnout

Discussions are led by a variety of experienced preceptors to provide insight, strategies, and resources for pharmacy residents.


Bradley J. Monk, MD, FACS, FACOG

Latest:

Practice Pearl 3: Reducing Costs of PARPi for Ovarian Cancer Treatment

Experts in gynecologic oncology provide insight on available patient assistance programs to help lower costs of PARP inhibitors for the treatment of ovarian cancer, and how pharmacists can aid in obtaining this information.


Libby Baney, JD

Latest:

Pharmacists Play a Critical Role in Protecting Patients From Illegal Online Drug Sellers

Although approximately 95% of online drug sellers operate illegally, many consumers may never know the medications they receive are not what they claim to be.


Katelyn Galli, PharmD, BCCP

Latest:

Counseling Patients About the Importance of Appropriate Pen Needle Administration

As use of injectable medications increases for diabetes and other indications, proper administration is crucial.


Vincent Chung, MD

Latest:

ASCO 2025: Insights on NALIRIFOX Use in Metastatic Pancreatic Ductal Adenocarcinoma From the NAPOLI-3 Trial

Vincent Chung, MD, discusses key findings from the NAPOLI-3 trial and offers guidance for pharmacists on managing toxicities, adjusting dosing, and supporting patients receiving NALIRIFOX for metastatic pancreatic ductal adenocarcinoma.


Mona El-Mouwfi, PharmD Candidate

Latest:

Headache or Harm: A Pharmacist’s Role in Differentiating Complement Inhibitor Adverse Effects

Pharmacists play a crucial role in managing headaches in patients on complement inhibitors for PNH, ensuring proper education and risk mitigation strategies.


Jenna Januszka, PharmD

Latest:

Monkeypox Treatment and Prevention: Stopping the Latest Outbreak

There is not yet an FDA-approved treatment available for monkeypox, but existing antiviral agents have been found to be effective in vitro and in animal studies.


Anu Tirupasur

Latest:

Learn to Mitigate Feelings of Burnout and Stress

Lack of acknowledgement or rewards in high-pressure pharmacy environments can lead to mental health issues.




Bradley Burk, PharmD, BCPP

Latest:

Educational Resources to Support Patients

Panelists discuss how comprehensive educational resources are essential for empowering patients with TD to better understand their condition, actively participate in their treatment decisions, and achieve optimal outcomes through improved self-management and adherence.


Jeremy Frens, PharmD, BCIDP

Latest:

Evaluation of Antibiotic Administration Surrounding Interventional Radiology Procedures

Implementation of a guidance document for periprocedural antibiotic prophylaxis resulted in improved appropriateness of antibiotic dose, selection, and duration for interventional radiology procedures.


Luis A. Valcarcel, PharmD Candidate

Latest:

Changing the Game: Pharmacy Students' Perspective on Naloxone OTC Approval

To eliminate the existing stigma in the community, addiction must be recognized as a treatable condition rather than an immoral act.


Craig A. Stevens, PharmD, BCPS

Latest:

Assessing Prescriber Justification for Use of Outpatient Chemotherapy in the Acute Care Setting

This single-center, descriptive, retrospective chart review identified barriers to outpatient chemotherapy use, revealing avoidable inpatient stays and highlighting targets for stewardship interventions.



Stephanie Ostling Mason, PharmD, CDCES

Latest:

New CMS Rules Underscore Pharmacists’ Role in Improving Glycemic Management

The measures will also affect workers across all areas of the hospital, including dietitians, information technology, nurses, and physicians.


Aric Logsdon, PhD

Latest:

Topical Ketamine: A Promising New Avenue for PTSD Treatment

Ketamine topical cream may alleviate symptoms of PTSD without causing the adverse effects and abuse potential often associated with other forms of ketamine administration.


Jacob Coomes, PharmD

Latest:

Empowering Diabetes Care: The Evolving Role of Pharmacists

Pharmacists are well-positioned to address diabetes from a multifaceted approach.

© 2025 MJH Life Sciences

All rights reserved.